Investigation of the Effect of Inhibition of CYP3A4/5 by Itraconazole on the PK of CHF6001 (Tanimilast)
Clinical trial NCT04739774 · COMPLETED
Trial details
- NCT number
- NCT04739774
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-22
- Primary completion
- 2021-04-20
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.